Combined Anti-VEGF and Anti–CTLA-4 Therapy Elicits Humoral Immunity to Galectin-1 Which Is Associated with Favorable Clinical Outcomes
暂无分享，去创建一个
A. Giobbie-Hurder | M. Shipp | G. Dranoff | F. Hodi | S. Rodig | Jun Zhou | D. Lawrence | J. Ouyang | G. Murphy | D. McDermott | Xinqi Wu | Jingjing Li | X. Liao | M. Piesche | E. Connolly | Matthias Piesche | X. Liao | Ouyang Jing